1. Home
  2. KBH vs HAE Comparison

KBH vs HAE Comparison

Compare KBH & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KB Home

KBH

KB Home

HOLD

Current Price

$62.29

Market Cap

4.1B

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$79.78

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KBH
HAE
Founded
1957
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.7B
IPO Year
1987
1991

Fundamental Metrics

Financial Performance
Metric
KBH
HAE
Price
$62.29
$79.78
Analyst Decision
Hold
Buy
Analyst Count
13
9
Target Price
$67.17
$88.38
AVG Volume (30 Days)
1.1M
839.6K
Earning Date
12-18-2025
02-05-2026
Dividend Yield
1.59%
N/A
EPS Growth
N/A
42.54
EPS
7.17
3.44
Revenue
$6,541,735,000.00
$1,327,850,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6.01
P/E Ratio
$8.78
$23.28
Revenue Growth
N/A
N/A
52 Week Low
$48.90
$47.32
52 Week High
$72.64
$87.32

Technical Indicators

Market Signals
Indicator
KBH
HAE
Relative Strength Index (RSI) 47.33 57.08
Support Level $61.23 $79.23
Resistance Level $66.18 $82.41
Average True Range (ATR) 1.77 2.32
MACD -0.14 -1.37
Stochastic Oscillator 23.23 11.81

Price Performance

Historical Comparison
KBH
HAE

About KBH KB Home

KB Home is an American construction company that focuses on residential construction in the United States. The company builds single-family homes and communities across different geographical segments which include the West Coast which also derives the majority of the revenue, Southwest, Central, and Southeast. The company operates in several markets and focuses on first-time and move-up homebuyers. It also invests in land acquisition and development to support future building activities and is also engaged in financial services operations which includes providing mortgage banking services through its joint venture with a third party.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: